Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Medicine (3)
British Journal of Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Medical research
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Nageatte Ibrahim Clear advanced filters

Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Antoni Ribas
Donald Lawrence
Omid Hamid
Amendments and Corrections02 Jul 2019
Nature Medicine

Volume: 25, P: 1319
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Triple therapy combining BRAF and MEK inhibitors with immune checkpoint blockade may benefit a subset of patients with BRAF ^V600-mutated metastatic melanoma.

Antoni Ribas
Donald Lawrence
Omid Hamid
Research06 Jun 2019
Nature Medicine

Volume: 25, P: 936-940
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

A randomized phase 2 trial testing triple combination of BRAF, MEK and PD-1 inhibition as first-line therapy in patients with BRAF-mutant melanoma shows durable responses and encouraging progression-free survival.

Paolo Antonio Ascierto
Pier Francesco Ferrucci
Antoni Ribas
Research06 Jun 2019
Nature Medicine

Volume: 25, P: 941-946
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

Omid Hamid
Caroline Robert
Marcus Butler
ResearchOpen Access11 Sept 2018
British Journal of Cancer

Volume: 119, P: 670-674